Showing results (51-60 of 151) with videos related to
Sort By:
Pageof 16
Cardiovascular Drug Reviews|February 24, 2004
KC 12291: an atypical sodium channel blocker with myocardial antiischemic propertiesGareth W John, Robert Létienne, Bruno Le Grand, et al.Cardiovascular Drug Reviews|February 24, 2004
Therapeutic potentials of sarpogrelate in cardiovascular diseaseHarjot K Saini, Nobuakira Takeda, Ramesh K Goyal, et al.Cardiovascular Drug Reviews|June 5, 2004
Bimatoprost: a novel antiglaucoma agentDavid F Woodward, R L Phelps, A H-P Krauss, et al.Cardiovascular Drug Reviews|July 12, 2005
Saga of renin-angiotensin system and calcium channels in hypertensive diabetics: does it have a therapeutic edge?Arun H S Kumar, P RamaraoCardiovascular Drug Reviews|July 12, 2005
Oxidative stress and cardiovascular disease: antioxidants and unresolved issuesKamakshi Sachidanandam, Susan C Fagan, Adviye ErgulCardiovascular Drug Reviews|July 12, 2005
Development of the thyroid hormone receptor beta-subtype agonist KB-141: a strategy for body weight reduction and lipid lowering with minimal cardiac side effectsGary J Grover, Karin Mellstrom, Johan MalmCardiovascular Drug Reviews|July 12, 2005
Preclinical profile of PF9404C, a nitric oxide donor with beta receptor blocking propertiesMercedes Villarroya, Manuela G López, Ricardo de Pascual, et al.Cardiovascular Drug Reviews|July 12, 2005
Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396Ming Li, J Bondo Hansen, Luping Huang, et al.Cardiovascular Drug Reviews|January 12, 2007
Preclinical studies with adrenomedullin and its binding protein as cardiovascular protective agents for hemorrhagic shockRongqian Wu, Ping WangCardiovascular Drug Reviews|January 12, 2007
IB-MECA and cardioprotectionZhelong Xu, Yeongho Jang, Robert A Mueller, et al.Pageof 16